Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MGUS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02933021
What this trial is testing

Unravel MGUS (Monoclonal Gammopathy of Unknown Significance)

Who this might be right for
Monoclonal Gammopathy of Unknown Significance
RxCelerate Ltd 664
Large-scale testing (Phase 3)Study completedNCT00661999
What this trial is testing

Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Mayo Clinic 502
Large-scale testing (Phase 3)Study completedNCT00666211
What this trial is testing

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
Vanderbilt-Ingram Cancer Center 98
Not applicableStudy completedNCT05119309
What this trial is testing

MGRS: Clinical-histological Features of a Multicenter Case Series

Who this might be right for
Monoclonal Gammopathy of Renal Significance
University of Milano Bicocca 87
Not applicableStudy completedNCT04615572
What this trial is testing

Screening to Improve Survival in AL Amyloidosis

Who this might be right for
Smoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
Tufts Medical Center 35
Not applicableLooking for participantsNCT06055894
What this trial is testing

A Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

Who this might be right for
Multiple Myeloma, SmolderingMultiple MyelomaMonoclonal Gammopathy of Undetermined Significance
Memorial Sloan Kettering Cancer Center 200
Not applicableUnknownNCT06489613
What this trial is testing

Screening for Monoclonal Gammopathy in Individuals Undergoing Physical Examinations Using iMS-LC Assay Technology.

Who this might be right for
M ProteinMonoclonal GammopathyMonoclonal Gammopathy of Undetermined Significance
Jian Li 15,600
Testing effectiveness (Phase 2)Active Not RecruitingNCT04614558
What this trial is testing

Isatuximab in Patients With Monoclonal Gammopathy of Renal Significance

Who this might be right for
Monoclonal Gammopathy
Columbia University 12
Testing effectiveness (Phase 2)Study completedNCT00099047
What this trial is testing

Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaSmoldering Multiple Myeloma
National Cancer Institute (NCI) 23
Not applicableUnknownNCT04727294
What this trial is testing

MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance+1 more
HealthTree Foundation 1,500
Testing effectiveness (Phase 2)Study completedNCT00245037
What this trial is testing

Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
OHSU Knight Cancer Institute 147
Testing effectiveness (Phase 2)Looking for participantsNCT06140524
What this trial is testing

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Smoldering Multiple Myeloma (SMM)
Regeneron Pharmaceuticals 116
Testing effectiveness (Phase 2)Study completedNCT00416624
What this trial is testing

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Mayo Clinic 239
Early research (Phase 1)Study completedNCT00002980
What this trial is testing

Decitabine in Treating Patients With Melanoma or Other Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
California Cancer Consortium
Not applicableLooking for participantsNCT06644625
What this trial is testing

CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study

Who this might be right for
Multiple MyelomaMultiple Myeloma ProgressionMonoclonal Gammopathy of Undetermined Significance (MGUS)+2 more
Wake Forest University Health Sciences 1,665
Not applicableActive Not RecruitingNCT05831358
What this trial is testing

Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program

Who this might be right for
Multiple MyelomaMonoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma
Case Comprehensive Cancer Center 201
Testing effectiveness (Phase 2)Study completedNCT00255749
What this trial is testing

Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Jonsson Comprehensive Cancer Center 89
Testing effectiveness (Phase 2)UnknownNCT05114109
What this trial is testing

Isatuximab in Type I Cryoglobulinemia

Who this might be right for
Multiple MyelomaMonoclonal Gammopathy of Undetermined SignificanceCryoglobulinemic Vasculitis
Assistance Publique - Hôpitaux de Paris 21
Not applicableEnded earlyNCT01109407
What this trial is testing

Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)

Who this might be right for
Smoldering MyelomaMonoclonal Gammopathy of Undetermined Significance
National Cancer Institute (NCI) 225
Testing effectiveness (Phase 2)Active Not RecruitingNCT04850846
What this trial is testing

Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma
Dana-Farber Cancer Institute 60
Next Page